| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/31/2012 | US8106155 Detection of antibiotic in sample; obtain sample, incubate with solid support, detect signal, determine concentration of antibiotic |
| 01/31/2012 | US8106052 Luminescence-based methods and probes for measuring cytochrome P450 activity |
| 01/31/2012 | US8106028 MicroRNA-21 antagonists and its target PDCD4 for use in the treatment of a glioma |
| 01/31/2012 | US8106024 Method of treating cancer with an RPN2 gene expression inhibitor |
| 01/31/2012 | US8105982 Aptamers and methods for their in vitro selection and uses thereof |
| 01/31/2012 | US8105847 Nano-sized optical fluorescence labels and uses thereof |
| 01/31/2012 | US8105846 Methods using pores |
| 01/31/2012 | US8105836 Chemical inhibitors of mismatch repair |
| 01/31/2012 | US8105828 Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals |
| 01/31/2012 | US8105821 Silane mixtures |
| 01/31/2012 | US8105800 Composition for assaying glycated proteins |
| 01/31/2012 | US8105799 Using transforming growth factor-beta -activated kinase-1 (TAK-1) and TAK1 binding protein 1(TAB-1) as evaluative tool in detection of modulators of interleukin and tumor necrosis factor activities |
| 01/31/2012 | US8105791 Marker for stem cells and its use |
| 01/31/2012 | US8105787 Applications of nucleic acid fragments |
| 01/31/2012 | US8105786 Method of producing a low molecular weight organic compound in a cell |
| 01/31/2012 | US8105785 Mylks as modifiers of branching morphogenesis and methods of use |
| 01/31/2012 | US8105784 Method for pairwise sequencing of target polynucleotides |
| 01/31/2012 | US8105783 Microfluidic cartridge |
| 01/31/2012 | US8105782 Materials and methods relating to nucleic acid amplification and profiling |
| 01/31/2012 | US8105781 Predictors of long-term mortality following coronary artery bypass graft surgery |
| 01/31/2012 | US8105780 Device and method of detecting mutations and polymorphisms in DNA |
| 01/31/2012 | US8105779 Compositions and methods for detecting the presence of Cryptosporidium parvum in a test sample |
| 01/31/2012 | US8105778 Hybridization chain reaction |
| 01/31/2012 | US8105777 Methods for diagnosis and/or prognosis of colon cancer |
| 01/31/2012 | US8105776 Breed-specific haplotypes for polled phenotypes in cattle |
| 01/31/2012 | US8105775 IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| 01/31/2012 | US8105774 Using peroxisome proliferator-activated receptor gamma, coactivator 1 beta (PGC-1Beta) as tool to identify modulators for treatment of free radical associated disorders |
| 01/31/2012 | US8105773 Oligonucleotides for cancer diagnosis |
| 01/31/2012 | US8105772 DNA detection method using molecular beacon with the use of monomer emission/excimer emission switching of fluorescent molecule |
| 01/31/2012 | US8105771 Random array DNA analysis by hybridization |
| 01/31/2012 | US8105770 Method of detecting amplification or deletion in genomic DNA Fragment |
| 01/31/2012 | US8105769 Using allelic variation in epidermal growth factor receptor (EGFR) gene as evaluative tool in predicting positive response to antitumor treatments/therapies |
| 01/31/2012 | US8105768 Methods of identifying patients for treatment with HER-2/neu inhibitors based on detection of HER-2/neu and TOP2A gene copy number |
| 01/31/2012 | US8105767 Cells for detection of enteroviruses |
| 01/31/2012 | US8105766 Method of measuring pyrophosphate |
| 01/31/2012 | US8105610 Method of making novel erythrovirus V9 VP2 capsid polypeptides |
| 01/31/2012 | US8105609 Administering a vaccine of a nucleic acid having a transcriiptional unit (TU) to direct a host cell to to biosynthesize the matrix and envelope (M and E) protein antigens; the TU comprises a prM signal sequence and ribosomal bindng sequence; carriers; encephalitis and yellow fever |
| 01/31/2012 | US8105606 Chimeric proteins that induce effects directed against viruses |
| 01/31/2012 | US8105584 Method for treating pervasive development disorders |
| 01/31/2012 | US8105553 Apparatus for operating microfluidic device comprising platen having face with fluid ports therein, fluid ports spatially corresponding to inlets on surface of microfluidic device, platform for holding microfluidic device relative to platen, actuator for urging platen against device to change pressure |
| 01/31/2012 | US8105478 Method for measuring the concentration or change in concentration of a redox-active substance and corresponding device |
| 01/31/2012 | US8105477 System and method for electrochemical detection of biological compounds |
| 01/31/2012 | US8105476 Integrated lancing and measurement device |
| 01/31/2012 | US8104533 Spray nozzle apparatus and method of use |
| 01/31/2012 | US8104515 Microfabricated elastomeric valve and pump systems |
| 01/31/2012 | US8104497 Microfabricated elastomeric valve and pump systems |
| 01/31/2012 | CA2557997C Determination of analyte characteristics based upon binding properties |
| 01/31/2012 | CA2544847C Methods and compositions for detection of segmented negative strand rna viruses |
| 01/31/2012 | CA2496897C Methods and compositions for modulating xbp-1 activity |
| 01/31/2012 | CA2474509C Methods and algorithms for cell enumeration in a low-cost cytometer |
| 01/31/2012 | CA2411816C Preparing a sample to be analysed from a sample with very large volume |
| 01/31/2012 | CA2393575C Monitoring oligonucleotide binding processes using chemiluminescence quenching |
| 01/31/2012 | CA2371658C Method for the identification and/or the quantification of a target compound |
| 01/31/2012 | CA2365780C Carriers having biological substance |
| 01/31/2012 | CA2285672C Purified telomerase |
| 01/31/2012 | CA2274989C Cloned glucagon-like peptide-2 receptors |
| 01/26/2012 | WO2012012803A2 Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
| 01/26/2012 | WO2012012797A2 Methods for isolating and using a subset of cd8 t-cells that are resistant to cyclosporin |
| 01/26/2012 | WO2012012779A2 System and method including analytical units |
| 01/26/2012 | WO2012012742A2 Crystal structure of human alpha-n-acetylglucosaminidase |
| 01/26/2012 | WO2012012739A2 Multiple input biologic classifier circuits for cells |
| 01/26/2012 | WO2012012717A1 Methods of detecting prenatal or pregnancy-related diseases or conditions |
| 01/26/2012 | WO2012012714A2 Methods of detecting neurological or neuropsychiatric diseases or conditions |
| 01/26/2012 | WO2012012709A2 Methods of detecting cardiovascular diseases or conditions |
| 01/26/2012 | WO2012012704A2 Methods of detecting kidney-associated diseases or conditions |
| 01/26/2012 | WO2012012703A2 Identification of differentially represented fetal or maternal genomic regions and uses thereof |
| 01/26/2012 | WO2012012694A2 Methods of detecting autoimmune or immune-related diseases or conditions |
| 01/26/2012 | WO2012012693A2 Methods for detecting signatures of disease or conditions in bodily fluids |
| 01/26/2012 | WO2012012689A2 Circulating micrornas are biomarkers of various diseases |
| 01/26/2012 | WO2012012571A1 Biolayer interferometry measurement of biological targets |
| 01/26/2012 | WO2012012527A2 Method for linking point of care rapid diagnostic testing results to laboratory-based methods |
| 01/26/2012 | WO2012012510A2 Gene expression profiling for the identification of lung cancer |
| 01/26/2012 | WO2012012458A1 Methods and systems for analysis of single cells |
| 01/26/2012 | WO2012012377A2 Detector arrangement for blood culture bottles with colorimetric sensors |
| 01/26/2012 | WO2012012278A2 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex |
| 01/26/2012 | WO2012012225A2 Predicting cancer outcome |
| 01/26/2012 | WO2012012135A2 Analyte sensor |
| 01/26/2012 | WO2012012106A2 Device for rapidly detecting microorganisms |
| 01/26/2012 | WO2012012104A1 Microbial detection system and methods |
| 01/26/2012 | WO2012012055A2 Method for monitoring a sterilization process |
| 01/26/2012 | WO2012012051A2 Method for multicolor codetection of microrna and proteins |
| 01/26/2012 | WO2012012037A1 Oligonucleotide adaptors: compositions and methods of use |
| 01/26/2012 | WO2012011952A2 Copy number variant-dependent genes as diagnostic tools, predictive biomarkers and therapeutic targets |
| 01/26/2012 | WO2012011778A2 Cancer diagnosis kit and pharmaceutical composition for prevention or treatment of cancer |
| 01/26/2012 | WO2012011777A2 Kit for diagnosing colorectal cancer and pharmaceutical composition for prevention or treatment of colorectal cancer |
| 01/26/2012 | WO2012011660A2 Method of manufacturing micro chamber plate with built-in sample and analytic micro chamber plate, analytic micro chamber plate and apparatus set for manufacturing analytic micro chamber plate with built-in sample |
| 01/26/2012 | WO2012011563A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 01/26/2012 | WO2012011557A1 Method for predicting onset risk of herpes zoster |
| 01/26/2012 | WO2012011556A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 01/26/2012 | WO2012011554A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 01/26/2012 | WO2012011379A1 Method for detecting nucleic acid amplification in sample and device therefor |
| 01/26/2012 | WO2012011144A2 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom. |
| 01/26/2012 | WO2012011085A2 A kit for detection of donkey meat in meat products |
| 01/26/2012 | WO2012010905A2 Assays for screening drug safety |
| 01/26/2012 | WO2012010708A1 Method, device and test kit for molecular-biological reactions |
| 01/26/2012 | WO2012010668A1 Novel substrates the fluorescence of which is suppressed, preparation thereof, and use thereof for identifying, detecting, and assaying legionella pneumophilia |
| 01/26/2012 | WO2012010661A1 Methods for determining a prognosis for survival for a patient with leukaemia |
| 01/26/2012 | WO2012010617A2 Method for identifying inhibitors against chikungunya virus |
| 01/26/2012 | WO2012010584A1 Complex mirna sets as novel biomarkers for gastric cancer |
| 01/26/2012 | WO2012010308A1 Zwitterion buffer containing compositions and uses in electroanalytical devices and methods |